Related references
Note: Only part of the references are listed.Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
Romina di Giuseppe et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)
Sympathetic Activation Induces Skeletal Fgf23 Expression in a Circadian Rhythm-dependent Manner
Masanobu Kawai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Vitamin D Is a Regulator of Endothelial Nitric Oxide Synthase and Arterial Stiffness in Mice
Olena Andrukhova et al.
MOLECULAR ENDOCRINOLOGY (2014)
Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction-A randomised controlled trial
Miles D. Witham et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction
Soochan Bae et al.
JOURNAL OF APPLIED PHYSIOLOGY (2013)
Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
Kensaku Shibata et al.
PLOS ONE (2013)
Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients
Nihil Chitalia et al.
ATHEROSCLEROSIS (2012)
FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway
Olena Andrukhova et al.
BONE (2012)
Fibroblast Growth Factor 23 and Inflammation in CKD
Fair Aunoz Mendoza et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
Max Plischke et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
Aline Martin et al.
PHYSIOLOGICAL REVIEWS (2012)
Klotho Lacks a Vitamin D Independent Physiological Role in Glucose Homeostasis, Bone Turnover, and Steady-State PTH Secretion In Vivo
Rene Anour et al.
PLOS ONE (2012)
Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
Jian Xie et al.
NATURE COMMUNICATIONS (2012)
Prevalence of Vitamin D Deficiency in Patients With Acute Myocardial Infarction
John H. Lee et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy
Songcang Chen et al.
CIRCULATION (2011)
The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
Sarah Seiler et al.
EUROPEAN HEART JOURNAL (2011)
Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure
Jinghong Luo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Vitamin D Deficiency Is Associated with Depletion of Circulating Endothelial Progenitor Cells and Endothelial Dysfunction in Patients with Type 2 Diabetes
Yuen-Fung Yiu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Vitamin D Status Is Associated With Arterial Stiffness and Vascular Dysfunction in Healthy Humans
Ibhar Al Mheid et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Systematic Review: Vitamin D and Cardiometabolic Outcomes
Anastassios G. Pittas et al.
ANNALS OF INTERNAL MEDICINE (2010)
Arterial Stiffness and Cardiovascular Events The Framingham Heart Study
Gary F. Mitchell et al.
CIRCULATION (2010)
Vitamin D in Atherosclerosis, Vascular Disease, and Endothelial Function
LaPrincess C. Brewer et al.
CURRENT DRUG TARGETS (2010)
FGF-23: More Than a Regulator of Renal Phosphate Handling?
Harald Jueppner et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
Soban Umar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Oxidative stress and left ventricular remodelling after myocardial infarction
Masatsugu Hori et al.
CARDIOVASCULAR RESEARCH (2009)
Vitamin D and the Cardiovascular System
Jorge N. Artaza et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Prevention of heart failure - A scientific statement from the American Heart Association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; Quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group
Douglas D. Schocken et al.
CIRCULATION (2008)
Role of endogenous bone marrow cells in long-term repair mechanisms after myocardial infarction
Kathrin I. Odoerfer et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey
Robert Scragg et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice
Martina Hesse et al.
MATRIX BIOLOGY (2007)
Mineral metabolism and arterial functions in end-stage renal disease:: Potential role of 25-hydroxyvitamin D deficiency
Gerard M. London et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
Circulating FGF-23 is regulated by 1α,25-dihydroxyvitamin D3 and phosphorus in vivo
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction
S Janssens et al.
CIRCULATION RESEARCH (2004)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
